Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Teva rivals advance on oral MS drug: Merck KGaA and Novartis have completed Phase III trials of their drugs, and are filing for approval
Trading Markets
Thursday, October 1, 2009 - 6:27pm
tags:
Teva Pharmaceuticals, Novartis, multiple sclerosis, Merck KGaA
Impax shipping generic of ADHD drug Adderall XR
Yahoo/AP
Thursday, October 1, 2009 - 4:57pm
tags:
Impax, ADHD, generics, Shire, Adderall
A tale of Novartis vs. Roche
Fierce Pharma
Thursday, October 1, 2009 - 4:22pm
tags:
Novartis, Roche
Cell Therapeutics' Opaxio Data Not Terrible
TheStreet.com
Thursday, October 1, 2009 - 4:20pm
tags:
Cell Therapeutics, Opaxio, cancer
Johnson & Johnson: Well Positioned for Growth
Seeking Alpha
Thursday, October 1, 2009 - 4:18pm
tags:
JNJ
Actavis launches challenge to Pfizer drug
FT.com
Thursday, October 1, 2009 - 4:17pm
tags:
Pfizer, Actavis, Lipitor, patents, generics
Why I'm Invested in Tysabri and Elan
Motley Fool
Thursday, October 1, 2009 - 4:16pm
tags:
Tysabri, Elan, Biogen Idec, MS, multiple sclerosis
[video] Biotech Safe From Congress
TheStreet.com
Thursday, October 1, 2009 - 4:15pm
tags:
biotech, healthcare reform
Surviving Wednesday's Wild Ride in Healthcare and Biotech
Seeking Alpha
Thursday, October 1, 2009 - 10:40am
tags:
biotech, Caraco, Senomyx, Sucampo, Orexigen, Vivus, Sequenom, Biocryst
Glaxo Kidney Cancer Drug Has Liver Risk, FDA Says
Bloomberg
Thursday, October 1, 2009 - 9:43am
tags:
GSK, kidney cancer, pazopanib
AstraZeneca on Suicide Mission in Drug Pricing Litigation
BNET Pharma
Thursday, October 1, 2009 - 9:41am
tags:
drug pricing, AstraZeneca, Zoladex, Medicare
BioCryst Updates the Obvious
TheStreet.com
Thursday, October 1, 2009 - 9:40am
tags:
Biocryst, Flu, peramivir
Abbott Records a 35% Reduction in Oil and Gas Usage
Seeking Alpha
Thursday, October 1, 2009 - 9:38am
tags:
Abbott Laboratories, environmental concerns
Sanofi expands R&D pipeline with two biotech deals
Reuters
Thursday, October 1, 2009 - 9:18am
tags:
Sanofi, R&D, Fovea, M&A, Merrimack Pharmaceuticals
Facet Biotech's board recommends shareholders reject Biogen Idec's $356 million tender offer
Yahoo/AP
Thursday, October 1, 2009 - 9:13am
tags:
M&A, Facet Biotech, Biogen Idec
Biogen Idec options trading soars
Boston Globe, MA
Thursday, October 1, 2009 - 9:10am
tags:
Biogen Idec, M&A, JNJ
Eli Lilly Still Range-Bound Despite a Bet Otherwise
Seeking Alpha
Thursday, October 1, 2009 - 9:01am
tags:
Eli Lilly
Sanofi-Aventis Signs Deal to Buy France's Fovea
Smart Money
Thursday, October 1, 2009 - 8:57am
tags:
Sanofi, France, M&A, Fovea
China Requires One Divestiture for Pfizer / Wyeth Merger
Seeking Alpha
Thursday, October 1, 2009 - 8:56am
tags:
China, M&A, Pfizer, Wyeth
The Novartis-AstraZeneca Deal Worst-Case Scenario
BNET Pharma
Thursday, October 1, 2009 - 7:35am
tags:
Novartis, AstraZeneca, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.